EPCAM and cancer: The latter activity relies on its ability to downregulate myosin contractility (Barth et al, 2018; Fagotto, 2020a; Gaston et al, 2021; Maghzal et al, 2013; Salomon et al, 2017), providing an obvious putative link between EpCAM and cancer metastasis that remains to be established.